Please rate topic.
Average 4.6 of 14 Ratings
A 48-year-old man who is scheduled to undergo total knee replacement has an X-linked clotting disorder that leads to abnormal bleeding and recurrent, spontaneous hemarthrosis. Before undergoing surgery, he should have replacement therapy of
protein C and S.
von Willebrand factor.
Select Answer to see Preferred Response